Abstract:Since 1992, the study of biological functions of HIV-1 gp41 has made great progress. Experimental evidence from several research groups demonstrated that gp41 has a putative cellular receptor. A recombinant soluble gp41 (aa539–684) and gp41 immunosuppressive peptide (aa583–599) could bind to human B lymphocytes and monocytes, but weakly bind to T lymphocytes. It was found that gp41 contains two cellular binding sites (aa583–599 and 641–675). GP41 could selectively inhibit cell proliferation of human T, B lymphocytes and monocytes, enhance human MHC class I, II and ICAM-1 molecule expression on cell surface. Gp41 binding proteins and a monoclonal antibody against the first binding site could inhibit this modulation effect. Amino acid sequence homology exists between gp41 and human type I interferons, and the homologous region is located in the first binding site on gp41 and in the receptor binding site on type I interferons. Studies in other groups indicate that both binding sites in gp41 may be associated with HIV infection of cells. Peptides containing two binding sites could respectively inhibit HIV infection of cells. A monoclonal antibody recognizing the second binding site could neutralize lab-strains and recently separated strains of HIV-1. Besides, antibodies against two regions (homologous with gp41 binding sites) of SIV transmembrane protein gp32 could protect macaques from SIV infection. These results suggest that the study of gp41 binding sites and cellular receptor could contribute to understanding the mechanism of HIV infection and to developing HIV vaccine and anti-HIV drugs.

HIV-1 Gp41 Binds to Several Proteins on the Human B-cell Line, Raji.

The Human Monocyte Cell Line U937 Binds HIV-1 Gp41 by Proteins of 37, 45, 49, 62 and 92 Kda.

HIV-1 gp41 binding proteins and antibodies to gp41 could inhibit enhancement of human raji cell mhc class I and II expression by gp41

Affinity Capillary Electrophoresis: Study of the Binding of HIV-1 Gp 41 with a Membrane Protein (P45) on the Human B Cell Line, Raji

Enhancement of HIV-1 gp41 binding to raji cells by pwm, lps, interferon-γ and interleukin-6

Biological Function Of Hiv-1 Transmembrane Protein Gp41 - A Study On A Putative Cellular Receptor Of Gp41

Biological Function of H1V-1 Transmembrane Protein Gp41

HIV-1 Gp41 by N-domain Binds the Potential Receptor Protein P45.

HIV-1 gp41 shares a common immunologic determinant with human T, B and monocyte cell lines

Human interferon-β inhibits binding of HIV-1 gp41 to lymphocyte and monocyte cells and binds the potential receptor protein P50 for HIV-1 gp41

The C Domain of HIV-1 Gp41 Binds the Putative Cellular Receptor Protein P62.

HIV-1 Gp41 Binding to Human T- and B-lymphocytes and Monocytes is Modulated by Phorbol Myristate Acetate (PMA)

Antibodies against human IFN-alpha and -beta recognized the immunosuppressive domain of HIV-1 gp41 and inhibit gp41-binding to the putative cellular receptor protein p45.

A Common Immunological Epitope Existing between HIV-1 gp41 and Human Interferon-α and -β

HIV-1 gp41 selectively inhibits spontaneous cell proliferation of human cell lines and mitogen- and recall antigen-induced lymphocyte proliferation

A Common Epitope on Gp41, IFN-α and IFN-β Induces Protective Activity

Antibodies against human IFN-α and -β recognized the immunosuppressive domain of HIV-1 gp41 and inhibit gp41-binding to the putative cellular receptor protein p45

Characterization of Interaction Between C-domain on HIV-1 Gp41 and the Putative Receptor Protein P62.

HIV-1 Gp41 by a Common Immunological Epitope Induces Increased Levels of Antibodies Against Human Interferon-Β in HIV-1 Positive Individuals

HIV-2 Transmembrane Protein gp36 Binds to the Putative Cellular Receptor Proteins P45 and P62

Human Immunodeficiency Virus Type 1 Gp41 Antibodies That Mask Membrane Proximal Region Epitopes: Antibody Binding Kinetics, Induction, and Potential for Regulation in Acute Infection.